Axcelis Technologies, Inc.
US ˙ NasdaqGS ˙ US0545402085

Introduction

This page provides a comprehensive analysis of the known insider trading history of R John Fletcher. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate R John Fletcher has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:CLPT / ClearPoint Neuro, Inc. Director 115,975
US:KRMD / KORU Medical Systems, Inc. Director 211,846
US:VYNT / Vyant Bio, Inc. Director 23,895
US:OPTN / OptiNose, Inc. Director 64,000
US:ACLS / Axcelis Technologies, Inc. Director 1,354
US:SPNC / Spectranetics Corp. (The) Director 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by R John Fletcher. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ACLS / Axcelis Technologies, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ACLS / Axcelis Technologies, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2014-05-22 ACLS FLETCHER R JOHN 5,000 1.7300 1,250 6.9200 8,650 361 12.84 7,400 85.55
2013-08-08 ACLS FLETCHER R JOHN 10,000 1.8400 2,500 7.3600 18,400
2012-05-25 ACLS FLETCHER R JOHN 5,000 1.0400 1,250 4.1600 5,200

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ACLS / Axcelis Technologies, Inc. Insider Trades
Insider Sales ACLS / Axcelis Technologies, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ACLS / Axcelis Technologies, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2021-02-17 ACLS FLETCHER R JOHN 6,881 39.0000 6,881 39.0000 268,359 152 34.0600 -33,992 -12.67
2020-05-28 ACLS FLETCHER R JOHN 50,750 26.5200 50,750 26.5200 1,345,890
2019-12-12 ACLS FLETCHER R JOHN 20,000 23.5200 20,000 23.5200 470,400
2019-12-11 ACLS FLETCHER R JOHN 22,500 22.9600 22,500 22.9600 516,600
2019-03-13 ACLS FLETCHER R JOHN 12,500 20.2600 12,500 20.2600 253,250
2019-03-13 ACLS FLETCHER R JOHN 10,000 20.2700 10,000 20.2700 202,700

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ACLS / Axcelis Technologies, Inc. Insider Trades
Insider Purchases CLPT / ClearPoint Neuro, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ACLS / Axcelis Technologies, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CLPT / ClearPoint Neuro, Inc. Insider Trades
Insider Sales CLPT / ClearPoint Neuro, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ACLS / Axcelis Technologies, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CLPT / ClearPoint Neuro, Inc. Insider Trades
Insider Purchases KRMD / KORU Medical Systems, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ACLS / Axcelis Technologies, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2021-05-17 KRMD FLETCHER R JOHN 25,000 4.3000 25,000 4.3000 107,500 18 4.79 12,250 11.40
2020-12-01 KRMD FLETCHER R JOHN 1,275 4.5300 1,275 4.5300 5,776
2020-11-30 KRMD FLETCHER R JOHN 21,052 4.4800 21,052 4.4800 94,313

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

KRMD / KORU Medical Systems, Inc. Insider Trades
Insider Sales KRMD / KORU Medical Systems, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ACLS / Axcelis Technologies, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

KRMD / KORU Medical Systems, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by R John Fletcher as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-07-02 2025-07-01 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 484 115,975 0.42 11.94 5,779 1,384,742
2025-07-02 2025-07-02 4 KRMD KORU Medical Systems, Inc.
Common Stock
A - Award 6,284 211,846 3.06 3.58 22,497 758,409
2025-05-19 2025-05-16 4 CLPT ClearPoint Neuro, Inc.
Common Stock
M - Exercise 21,093 115,491 22.34
2025-04-02 2025-04-02 4 KRMD KORU Medical Systems, Inc.
Common Stock
A - Award 8,806 205,562 4.48 2.56 22,543 526,239
2025-04-02 2025-04-01 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 486 94,398 0.52 11.89 5,779 1,122,392
2025-01-03 2025-01-03 4 KRMD KORU Medical Systems, Inc.
Common Stock
A - Award 5,905 196,756 3.09 3.81 22,498 749,640
2025-01-03 2025-01-02 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 375 93,912 0.40 15.38 5,768 1,444,367
2024-10-02 2024-10-01 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 515 93,537 0.55 11.21 5,773 1,048,550
2024-10-01 2024-10-01 4 KRMD KORU Medical Systems, Inc.
Common Stock
A - Award 8,181 190,851 4.48 2.75 22,498 524,840
2024-07-12 2024-07-11 4 KRMD KORU Medical Systems, Inc.
Common Stock
A - Award 8,371 182,670 4.80 2.71 22,685 495,036
2024-07-02 2024-07-01 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 1,072 93,022 1.17 5.39 5,778 501,389
2024-05-15 2024-05-14 4 CLPT ClearPoint Neuro, Inc.
Common Stock
M - Exercise 17,153 91,950 22.93
2024-04-02 2024-04-01 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 850 74,797 1.15 6.80 5,780 508,620
2024-04-01 2024-03-31 4 KRMD KORU Medical Systems, Inc.
Common Stock
A - Award 9,493 174,353 5.76 2.37 22,498 413,217
2024-01-03 2024-01-02 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 851 73,947 1.16 6.79 5,778 502,100
2024-01-02 2023-12-31 4 KRMD KORU Medical Systems, Inc.
Common Stock
A - Award 9,493 164,860 6.11 2.37 22,498 390,718
2023-10-03 2023-10-02 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 1,153 73,096 1.60 5.01 5,777 366,211
2023-10-03 2023-09-30 4 KRMD KORU Medical Systems, Inc.
Common Stock
A - Award 8,226 155,367 5.59 2.74 22,539 425,706
2023-07-05 2023-07-03 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 798 71,943 1.12 7.24 5,778 520,867
2023-07-05 2023-06-30 4 KRMD KORU Medical Systems, Inc.
Common Stock
A - Award 6,465 147,141 4.60 3.48 22,498 512,051
2023-04-05 2023-03-31 4/A KRMD KORU Medical Systems, Inc.
Common Stock
A - Award 5,281 140,676 3.90 4.26 22,497 599,280
2023-04-04 2023-04-03 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 684 71,145 0.97 8.44 5,773 600,464
2023-04-03 2023-03-31 4 KRMD KORU Medical Systems, Inc.
Common Stock
A - Award 5,281 140,380 3.91 4.26 22,497 598,019
2023-01-19 2023-01-17 4 VYNT Vyant Bio, Inc.
Common Stock, $0.0001 par value
A - Award 4,368 23,895 22.37
2023-01-04 2023-01-03 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 2,175 70,461 3.19 7.97 17,335 561,574
2023-01-03 2022-12-31 4 KRMD KORU Medical Systems, Inc.
Common Stock
A - Award 6,410 135,395 4.97 3.51 22,499 475,236
2022-10-19 2022-10-17 4 VYNT Vyant Bio, Inc.
Common Stock, $0.0001 par value
A - Award 8,290 97,649 9.28
2022-10-04 2022-10-03 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 1,702 68,286 2.56 10.19 17,343 695,834
2022-10-03 2022-09-30 4 KRMD KORU Medical Systems, Inc.
Common Stock
A - Award 10,022 128,985 8.42 2.25 22,550 290,216
2022-07-29 2022-07-18 4 VYNT Vyant Bio, Inc.
Common Stock, $0.0001 par value
A - Award 4,696 89,359 5.55
2022-07-06 2022-07-01 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 1,373 66,584 2.11 12.63 17,341 840,956
2022-07-05 2022-06-30 4 KRMD KORU Medical Systems, Inc.
Common Stock
A - Award 9,003 118,963 8.19 2.50 22,508 297,408
2022-05-27 2022-05-25 4 CLPT ClearPoint Neuro, Inc.
Stock Options (right to buy)
A - Award 6,179 6,179
2022-05-27 2022-05-25 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 9,269 65,211 16.57
2022-04-26 2022-04-26 4 OPTN OptiNose, Inc.
Stock Option (Right to Buy)
A - Award 64,000 64,000
2022-04-19 2022-04-18 4 VYNT Vyant Bio, Inc.
Common Stock, $0.0001 par value
A - Award 3,944 84,663 4.89
2022-04-13 2022-03-30 4 VYNT Vyant Bio, Inc.
Common Stock, $0.0001 par value
A - Award 24,844 80,719 44.46
2022-04-05 2022-04-01 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 1,741 55,942 3.21 9.96 17,340 557,182
2022-04-04 2022-03-31 4 KRMD REPRO MED SYSTEMS INC
Common Stock
A - Award 7,832 109,960 7.67 2.87 22,478 315,585
2022-04-01 2022-03-30 4 VYNT Vyant Bio, Inc.
Common Stock, $0.0001 par value
A - Award 43,478 55,875 350.71
2022-01-20 2022-01-18 4 VYNT Vyant Bio, Inc.
Common Stock, $0.0001 par value
A - Award 3,721 12,397 42.89 1.31 4,875 16,240
2022-01-04 2022-01-01 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 2,003 54,201 3.84 11.54 23,115 625,480
2022-01-03 2021-12-31 4 KRMD REPRO MED SYSTEMS INC
Common Stock
A - Award 7,500 102,128 7.93 3.00 22,500 306,384
2021-10-04 2021-09-30 4 KRMD REPRO MED SYSTEMS INC
Common Stock
A - Award 7,894 94,628 9.10 2.85 22,498 269,690
2021-10-04 2021-10-01 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 1,290 52,198 2.53 17.92 23,117 935,388
2021-07-06 2021-06-30 4 KRMD REPRO MED SYSTEMS INC
Common Stock
A - Award 3,744 86,734 4.51 4.63 17,335 401,578
2021-07-02 2021-06-30 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 771 50,908 1.54 20.26 15,620 1,031,396
2021-06-28 2021-06-25 4 CLPT ClearPoint Neuro, Inc.
Stock Options (right to buy)
A - Award 6,006 6,006
2021-06-28 2021-06-25 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 3,003 50,137 6.37
2021-05-24 2021-05-24 4 VYNT Vyant Bio, Inc.
Common Stock, $0.0001 par value
P - Purchase 15,300 30,300 102.00 3.39 51,835 102,653
2021-05-24 2021-05-21 4 VYNT Vyant Bio, Inc.
Common Stock, $0.0001 par value
P - Purchase 15,000 15,000 3.33 49,948 49,948
2021-05-18 2021-05-17 4 KRMD REPRO MED SYSTEMS INC
Common Stock
P - Purchase 25,000 82,990 43.11 4.30 107,500 356,857
2021-04-12 2021-03-31 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 738 47,134 1.59 19.57 14,443 922,412
2021-04-05 2021-03-31 4 KRMD REPRO MED SYSTEMS INC
Common Stock
A - Award 3,551 57,990 6.52 3.52 12,500 204,125
2021-04-01 2021-03-30 4 VYNT Vyant Bio, Inc.
Stock option (right to buy)
A - Award 13,015 13,015
2021-04-01 2021-03-30 4 VYNT Vyant Bio, Inc.
Stock option (right to buy)
J - Other 10,265 10,265
2021-04-01 2021-03-25 4 VYNT Vyant Bio, Inc.
Common Stock
A - Award 8,676 8,676
2021-02-17 2021-02-17 4 ACLS AXCELIS TECHNOLOGIES INC
Common Stock
S - Sale -6,881 1,354 -83.56 39.00 -268,359 52,806
2021-01-04 2020-12-31 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 808 46,396 1.77 15.00 12,120 695,940
2021-01-04 2020-12-31 4 KRMD REPRO MED SYSTEMS INC
Common Stock
A - Award 3,114 54,439 6.07 6.02 18,746 327,723
2020-12-01 2020-12-01 4 KRMD REPRO MED SYSTEMS INC
Common Stock
P - Purchase 1,275 51,325 2.55 4.53 5,776 232,502
2020-12-01 2020-11-30 4 KRMD REPRO MED SYSTEMS INC
Common Stock
P - Purchase 21,052 50,050 72.60 4.48 94,313 224,224
2020-10-02 2020-09-30 4 KRMD REPRO MED SYSTEMS INC
Common Stock
A - Award 2,597 28,998 9.84 7.22 18,750 209,366
2020-10-01 2020-09-30 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 2,124 45,588 4.89 5.71 12,128 260,307
2020-10-01 2020-09-30 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 2,124 45,588 4.89 5.71 12,128 260,307
2020-07-02 2020-06-30 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 3,411 43,464 8.52 3.55 12,109 154,297
2020-07-01 2020-06-30 4 KRMD REPRO MED SYSTEMS INC
Common Stock
A - Award 2,088 26,401 8.59 8.98 18,750 237,081
2020-06-17 2020-06-03 4 CLPT ClearPoint Neuro, Inc.
Stock Options (right to buy)
A - Award 15,000 15,000
2020-05-29 2020-05-28 4 ACLS AXCELIS TECHNOLOGIES INC
Common Stock
S - Sale -50,750 8,235 -86.04 26.52 -1,345,890 218,392
2020-05-15 2020-05-15 4 ACLS AXCELIS TECHNOLOGIES INC
Common Stock
A - Award 6,881 58,985 13.21
2020-04-02 2020-03-31 4 CLPT ClearPoint Neuro, Inc.
Common Stock
A - Award 3,396 40,053 9.26 3.57 12,124 142,989
2020-04-01 2020-03-31 4 KRMD REPRO MED SYSTEMS INC
Common Stock
A - Award 2,500 24,313 11.46 7.50 18,750 182,348
2020-01-09 2019-12-31 4/A KRMD REPRO MED SYSTEMS INC
Common Stock
A - Award 2,871 21,813 15.16 6.53 18,748 142,439
2020-01-02 2019-12-31 4 KRMD REPRO MED SYSTEMS INC
Common Stock
A - Award 1,914 20,856 10.10 6.53 12,498 136,190
2020-01-02 2019-12-31 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 2,445 36,657 7.15 4.96 12,127 181,819
2019-12-12 2019-12-12 4 ACLS AXCELIS TECHNOLOGIES INC
Stock Option (right to buy)
M - Exercise -10,000 0 -100.00
2019-12-12 2019-12-12 4 ACLS AXCELIS TECHNOLOGIES INC
Stock Option (right to buy)
M - Exercise -10,000 0 -100.00
2019-12-12 2019-12-12 4 ACLS AXCELIS TECHNOLOGIES INC
Common Stock
S - Sale -20,000 52,104 -27.74 23.52 -470,400 1,225,486
2019-12-12 2019-12-12 4 ACLS AXCELIS TECHNOLOGIES INC
Common Stock
M - Exercise 10,000 72,104 16.10 7.20 72,000 519,149
2019-12-12 2019-12-12 4 ACLS AXCELIS TECHNOLOGIES INC
Common Stock
M - Exercise 10,000 62,104 19.19 6.40 64,000 397,466
2019-12-11 2019-12-11 4 ACLS AXCELIS TECHNOLOGIES INC
Stock Option (right to buy)
M - Exercise -10,000 0 -100.00
2019-12-11 2019-12-11 4 ACLS AXCELIS TECHNOLOGIES INC
Stock Option (right to buy)
M - Exercise -12,500 0 -100.00
2019-12-11 2019-12-11 4 ACLS AXCELIS TECHNOLOGIES INC
Common Stock
S - Sale -22,500 52,104 -30.16 22.96 -516,600 1,196,308
2019-12-11 2019-12-11 4 ACLS AXCELIS TECHNOLOGIES INC
Common Stock
M - Exercise 10,000 74,604 15.48 7.96 79,600 593,848
2019-12-11 2019-12-11 4 ACLS AXCELIS TECHNOLOGIES INC
Common Stock
M - Exercise 12,500 64,604 23.99 6.40 80,000 413,466
2019-10-02 2019-09-30 4 REPR REPRO MED SYSTEMS INC
Common Stock
A - Award 1,582 18,942 9.11 3.95 6,249 74,821
2019-10-01 2019-09-30 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 2,355 34,212 7.39 5.15 12,128 176,192
2019-07-02 2019-06-28 4 REPR REPRO MED SYSTEMS INC
Common Stock
A - Award 1,312 17,360 8.18 2.88 3,779 49,997
2019-07-01 2019-06-28 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 3,829 31,857 13.66 3.17 12,138 100,987
2019-06-17 2019-06-14 4 REPR REPRO MED SYSTEMS INC
Common Stock
A - Award 16,048 16,048 2.18 34,985 34,985
2019-06-10 2019-06-07 4 MRIC MRI INTERVENTIONS, INC.
Stock Options (right to buy)
A - Award 15,000 15,000
2019-05-15 2019-05-15 4 ACLS AXCELIS TECHNOLOGIES INC
Common Stock
A - Award 6,232 52,104 13.59
2019-05-08 3 REPR REPRO MED SYSTEMS INC
Common Stock
0
2019-04-02 2019-03-29 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 3,854 28,028 15.94 3.15 12,140 88,288
2019-03-13 2019-03-13 4 ACLS AXCELIS TECHNOLOGIES INC
Stock option (right to buy)
M - Exercise -10,000 0 -100.00
2019-03-13 2019-03-13 4 ACLS AXCELIS TECHNOLOGIES INC
Stock option (right to buy)
M - Exercise -12,500 0 -100.00
2019-03-13 2019-03-13 4 ACLS AXCELIS TECHNOLOGIES INC
Common Stock
S - Sale -10,000 45,872 -17.90 20.27 -202,700 929,825
2019-03-13 2019-03-13 4 ACLS AXCELIS TECHNOLOGIES INC
Common Stock
M - Exercise 10,000 55,872 21.80 3.72 37,200 207,844
2019-03-13 2019-03-13 4 ACLS AXCELIS TECHNOLOGIES INC
Common Stock
S - Sale -12,500 45,872 -21.41 20.26 -253,250 929,367
2019-03-13 2019-03-13 4 ACLS AXCELIS TECHNOLOGIES INC
Common Stock
M - Exercise 12,500 58,372 27.25 1.76 22,000 102,735
2019-01-02 2018-12-31 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 8,248 24,174 51.79 1.47 12,125 35,536
2018-10-01 2018-09-28 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 6,900 15,926 76.45 1.76 12,144 28,030
2018-07-03 2018-06-29 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 5,394 9,026 148.51 2.18 11,759 19,677
2018-06-11 2018-06-08 4 MRIC MRI INTERVENTIONS, INC.
Stock Options (right to buy)
A - Award 15,000 15,000
2018-05-17 2018-05-16 4 ACLS AXCELIS TECHNOLOGIES INC
Common Stock
A - Award 5,637 45,872 14.01
2018-04-02 2018-03-30 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 3,632 3,632 3.13 11,368 11,368
2017-12-14 2017-12-12 4 MRIC MRI INTERVENTIONS, INC.
Stock Options (right to buy)
A - Award 13,875 13,875
2017-08-11 2017-08-09 4 SPNC SPECTRANETICS CORP
SPNC Common Stock
D - Sale to Issuer -141,697 0 -100.00 38.50 -5,455,334
2017-06-12 2017-06-08 4 SPNC SPECTRANETICS CORP
SPNC Common Stock
A - Award 4,780 141,697 3.49
2017-05-17 2017-05-17 4 ACLS AXCELIS TECHNOLOGIES INC
Common Stock
A - Award 3,802 40,235 10.44
2017-05-11 2017-05-09 4 MRIC MRI INTERVENTIONS, INC.
Stock Option (right to buy)
A - Award 1,125 1,125
2016-07-05 2016-06-30 4 SPNC SPECTRANETICS CORP
SPNC Common Stock
A - Award 6,949 136,917 5.35
2016-05-17 2016-05-16 4 ACLS AXCELIS TECHNOLOGIES INC
Common Stock
A - Award 30,545 145,730 26.52
2015-10-29 2015-10-28 4 SPNC SPECTRANETICS CORP
SPNC Common Stock
P - Purchase 8,240 129,968 6.77 12.04 99,201 1,564,685
2015-10-26 2015-10-26 4 SPNC SPECTRANETICS CORP
SPNC Common Stock
P - Purchase 8,000 121,728 7.03 12.41 99,297 1,510,900
2015-07-16 2015-07-15 4 ACLS AXCELIS TECHNOLOGIES INC
Common Stock
A - Award 16,000 115,185 16.13
2015-06-15 2015-06-12 4 SPNC SPECTRANETICS CORP
SPNC Common Stock
A - Award 3,774 113,728 3.43
2015-03-06 2015-03-06 4 SPNC SPECTRANETICS CORP
SPNC Stock Option Right To Buy
M - Exercise -45,000 0 -100.00 5.31 -238,950
2015-03-06 2015-03-06 4 SPNC SPECTRANETICS CORP
SPNC Common Stock
S - Sale -22,245 109,954 -16.83 34.35 -764,200 3,777,338
2015-03-06 2015-03-06 4 SPNC SPECTRANETICS CORP
SPNC Common Stock
M - Exercise 45,000 132,199 51.61 5.31 238,950 701,977
2014-07-17 2014-07-15 4 ACLS AXCELIS TECHNOLOGIES INC
Stock option (right to buy)
A - Award 40,000 40,000
2014-06-11 2014-06-10 4 SPNC SPECTRANETICS CORP
SPNC Restricted Stock Award
A - Award 4,467 87,199 5.40
2014-05-27 2014-05-22 4 ACLS AXCELIS TECHNOLOGIES INC
Common Stock
P - Purchase 5,000 99,185 5.31 1.73 8,650 171,590
2013-08-12 2013-08-08 4 ACLS AXCELIS TECHNOLOGIES INC
Common Stock
P - Purchase 10,000 94,185 11.88 1.84 18,400 173,300
2013-07-16 2013-07-15 4 ACLS AXCELIS TECHNOLOGIES INC
Stock option (right to buy)
A - Award 40,000 40,000
2013-05-31 2013-05-29 4 SPNC SPECTRANETICS CORP
SPNC Restricted Stock Award
A - Award 3,170 82,732 3.98
2012-11-05 2012-11-02 4 SPNC SPECTRANETICS CORP
SPNC Common Stock
P - Purchase 1,000 79,562 1.27 13.86 13,860 1,102,769
2012-07-17 2012-07-16 4 ACLS AXCELIS TECHNOLOGIES INC
Stock option (right to buy)
A - Award 40,000 40,000
2012-06-01 2012-05-31 4 SPNC SPECTRANETICS CORP
SPNC Restricted Stock Award
A - Award 6,079 78,562 8.39 9.87 60,000 775,407
2012-05-29 2012-05-25 4 SPNC SPECTRANETICS CORP
SPNC Common Stock
P - Purchase 2,601 72,483 3.72 9.96 25,906 721,931
2012-05-29 2012-05-25 4 SPNC SPECTRANETICS CORP
SPNC Common Stock
P - Purchase 3,399 69,882 5.11 9.90 33,650 691,832
2012-05-29 2012-05-25 4 ACLS AXCELIS TECHNOLOGIES INC
Common Stock
P - Purchase 5,000 84,185 6.31 1.04 5,200 87,552
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)